ResMed to Report Fourth Quarter Fiscal 2023 Earnings on August 3, 2023
- None.
- None.
SAN DIEGO, July 06, 2023 (GLOBE NEWSWIRE) -- ResMed (NYSE: RMD, ASX: RMD) today announced it plans to release financial and operational results for the fourth quarter of fiscal year 2023 on Thursday, August 3, 2023, after the New York Stock Exchange closes. Following the release, ResMed management will host a webcast to discuss the results. Other forward-looking and material information may also be discussed during the webcast.
Earnings webcast details:
| • | Location: | http://investor.resmed.com | ||
| • | Date: | Thursday, August 3, 2023 | ||
| • | Time: | 1:30 p.m. PDT / 4:30 p.m. EDT | ||
| • | International: | London, Thursday, August 3, 2023, 9:30 p.m. BST | ||
| Sydney, Friday, August 4, 2023, 6:30 a.m. AEST |
Please note, ResMed does not use outside phone lines to access the earnings call, the call is accessible via the above webcast link only.
A replay of the earnings webcast will be accessible on ResMed’s website and available approximately two hours after the webcast. In addition, a phone replay will be available approximately three hours after the webcast and will be accessible from August 3, 2023, until August 17, 2023, at:
| • | U.S.: +1 877.660.6853 | ||
| • | International: +1 201.612.7415 | ||
| • | Conference ID: 13739812 |
About ResMed
At ResMed (NYSE: RMD, ASX: RMD) we pioneer innovative solutions that treat and keep people out of the hospital, empowering them to live healthier, higher-quality lives. Our digital health technologies and cloud-connected medical devices transform care for people with sleep apnea, COPD, and other chronic diseases. Our comprehensive out-of-hospital software platforms support the professionals and caregivers who help people stay healthy in the home or care setting of their choice. By enabling better care, we improve quality of life, reduce the impact of chronic disease, and lower costs for consumers and healthcare systems in more than 140 countries. To learn more, visit ResMed.com and follow @ResMed.
| For investors | For media |
| Amy Wakeham | Jayme Rubenstein |
| +1 858.836.5000 | +1 508.769.8440 |
| investorrelations@resmed.com | news@resmed.com |
FAQ
When will ResMed release its Q4 FY2023 results?
What stock exchanges is ResMed listed on?
Where can I access the webcast to discuss ResMed's Q4 FY2023 results?
Will there be a replay of the webcast?
How long will the phone replay be available?
